세계의 감염성 창상 치료 관리 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 상처 유형별, 지역별, 경쟁(2020-2030년)
Infectious Wound Care Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Wound Type, By Region & Competition, 2020-2030F
상품코드:1748855
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 감염성 창상 치료 관리 시장 규모는 2024년 14억 2,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 7.13%를 나타낼 것으로 예측됩니다. 이 시장에는 부상이나 수술, 만성적인 건강 상태에 의해 생기는 감염성 창상을 예방, 치료, 관리하는 것을 목적으로 한 폭넓은 제품 및 서비스가 포함됩니다. 이러한 창상은 세균이나 진균 등 유해한 미생물의 존재에 의해 특징지어지며, 합병증을 예방하기 위해 전문적인 케어가 필요합니다. 제품에는 항균 드레싱 재료, 국소 항생제, 창상 세정제, 고급 케어 솔루션 등이 있습니다. 기술의 진보는 항균 성능과 조직 재생을 향상시킴으로써 창상 케어 제품의 유효성을 계속 높이고 있습니다. 당뇨병이나 비만 등의 만성 질환의 증가도 효과적인 창상 케어 솔루션에 대한 수요를 높이고 있습니다. 헬스케어 시스템은 세계적으로 조기 개입과 감염 대책을 중시하고 있기 때문에 감염성 창상 치료 관리 분야는 꾸준하고 지속적인 성장이 전망됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
14억 2,000만 달러
시장 규모(2030년)
21억 3,000만 달러
CAGR(2025-2030년)
7.13%
급성장 부문
당뇨병
최대 시장
북미
시장 성장 촉진요인
만성 질환 증가
주요 시장 과제
항균제 내성
주요 시장 동향
재생 의료
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
금액별
시장 점유율 및 예측
제품 유형별(치료제, 디바이스)
상처 유형별(당뇨병, 저산소증 및 조직 관류 불량, 기타)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
제품 시장 맵
제품 유형별
상처 유형별
지역별
제6장 북미의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
일본
인도
한국
호주
제9장 남미의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 감염성 창상 치료 관리 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
아랍에미리트(UAE)
사우디아라비아
남아프리카
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향 및 발전
합병 및 인수
제품 개발
최근 동향
제13장 Porter's Five Forces 분석
제14장 PESTEL 분석
제15장 경쟁 구도
Molnlycke Health Care AB
Hartmann Group
Smith & Nephew PLC
3M Company.
Smith & Nephew PLC
Medtronic Plc
B Braun Melsungen AG
Johnson & Johnson
Molnlycke Healthcare AB
Conva Tec Inc.
제16장 전략적 제안
제17장 기업 소개 및 면책사항
AJY
영문 목차
영문목차
The Global Infectious Wound Care Management Market was valued at USD 1.42 billion in 2024 and is projected to grow at a CAGR of 7.13% through 2030. This market encompasses a broad spectrum of products and services aimed at preventing, treating, and managing infectious wounds, which may arise from injuries, surgeries, or chronic health conditions. These wounds are characterized by the presence of harmful microorganisms such as bacteria or fungi and require specialized care to prevent complications. The product range includes antimicrobial dressings, topical antibiotics, wound cleansers, and advanced care solutions. Technological advancements continue to enhance the efficacy of wound care products by improving antimicrobial performance and tissue regeneration. The increasing prevalence of chronic conditions like diabetes and obesity has also heightened the demand for effective wound care solutions. As healthcare systems globally emphasize early intervention and infection control, the infectious wound care management sector is set to witness steady and sustained growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.42 Billion
Market Size 2030
USD 2.13 Billion
CAGR 2025-2030
7.13%
Fastest Growing Segment
Diabetes Mellitus
Largest Market
North America
Key Market Drivers
Rising Incidence of Chronic Diseases
The surge in chronic diseases is a major catalyst for the global Infectious Wound Care Management Market. According to the World Obesity Atlas 2024, the number of adults living with obesity is projected to rise from 0.81 billion in 2020 to 1.53 billion by 2035. Chronic conditions such as diabetes, vascular disorders, and autoimmune diseases frequently lead to non-healing wounds, pressure sores, and ulcers, all of which are highly susceptible to infection. These patients often require specialized wound care solutions due to compromised immunity and delayed healing. As the global population continues to age and the burden of non-communicable diseases escalates, healthcare providers are increasingly turning to advanced wound care technologies. The focus on infection prevention, patient recovery, and quality of life has intensified demand for effective infectious wound care management products, driving market expansion and encouraging innovation across product categories.
Key Market Challenges
Antimicrobial Resistance
Antimicrobial resistance (AMR) presents a substantial challenge to the Global Infectious Wound Care Management Market. AMR occurs when pathogens become resistant to antimicrobial agents, reducing the efficacy of traditional treatments such as antibiotics and antifungal medications. This phenomenon complicates the management of infected wounds, often leading to prolonged healing times, higher healthcare expenditures, and increased risk of severe complications. In the context of wound care, AMR diminishes the effectiveness of commonly used therapies, necessitating the development of alternative strategies. These may include novel antimicrobial compounds, combination therapies, or non-antibiotic interventions. Ensuring appropriate antibiotic use and implementing rigorous infection control protocols are critical in mitigating AMR. As the global health community continues to address this issue, innovation in resistant-pathogen management and infection prevention becomes increasingly vital to maintaining the effectiveness of wound care solutions.
Key Market Trends
Regenerative Medicine
Regenerative medicine is emerging as a transformative trend in the Infectious Wound Care Management Market. This field leverages the body's natural healing mechanisms through the application of technologies such as stem cell therapy, growth factors, and tissue engineering to accelerate wound healing and tissue repair. These approaches are particularly effective for treating chronic or complex infectious wounds that are unresponsive to conventional treatments. Stem cells promote regeneration by differentiating into the necessary cell types, while growth factors aid in tissue proliferation and remodeling. Regenerative solutions not only reduce healing time but also help prevent infections and improve long-term outcomes. Although still under active research, regenerative medicine is poised to revolutionize wound care, offering innovative alternatives that enhance patient recovery, reduce healthcare costs, and address complications arising from non-healing wounds.
Key Market Players
Molnlycke Health Care AB
Hartmann Group
Smith & Nephew PLC
3M Company
Medtronic Plc
B Braun Melsungen AG
Johnson & Johnson
Molnlycke Healthcare AB
Conva Tec Inc.
Report Scope:
In this report, the Global Infectious Wound Care Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Infectious Wound Care Management Market, By Product Type:
Therapeutics
Device
Infectious Wound Care Management Market, By Wound Type:
Diabetes Mellitus
Hypoxia/Poor Tissue Perfusion
Other
Infectious Wound Care Management Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Infectious Wound Care Management Market.
Available Customizations:
Global Infectious Wound Care Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Infectious Wound Care Management Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Therapeutics, Device)
5.2.2. By Wound Type (Diabetes Mellitus, Hypoxia/Poor Tissue Perfusion, Other)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2024)
5.3. Product Market Map
5.3.1. By Product Type
5.3.2. By Wound Type
5.3.3. By Region
6. North America Infectious Wound Care Management Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Wound Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Infectious Wound Care Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Wound Type
6.3.2. Canada Infectious Wound Care Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Wound Type
6.3.3. Mexico Infectious Wound Care Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Wound Type
7. Europe Infectious Wound Care Management Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Wound Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Infectious Wound Care Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Wound Type
7.3.2. France Infectious Wound Care Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Wound Type
7.3.3. United Kingdom Infectious Wound Care Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Wound Type
7.3.4. Italy Infectious Wound Care Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Wound Type
7.3.5. Spain Infectious Wound Care Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Wound Type
8. Asia-Pacific Infectious Wound Care Management Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Wound Type
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Infectious Wound Care Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Wound Type
8.3.2. Japan Infectious Wound Care Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Wound Type
8.3.3. India Infectious Wound Care Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Wound Type
8.3.4. South Korea Infectious Wound Care Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Wound Type
8.3.5. Australia Infectious Wound Care Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Wound Type
9. South America Infectious Wound Care Management Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Wound Type
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Infectious Wound Care Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Wound Type
9.3.2. Argentina Infectious Wound Care Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Wound Type
9.3.3. Colombia Infectious Wound Care Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Wound Type
10. Middle East and Africa Infectious Wound Care Management Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Wound Type
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Infectious Wound Care Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Wound Type
10.3.2. Saudi Arabia Infectious Wound Care Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Wound Type
10.3.3. South Africa Infectious Wound Care Management Market Outlook
